-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's right to use underlying asset under operating lease.
-
Summary
-
Biocryst Pharmaceuticals Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q3 2021 to Q3 2024.
- Biocryst Pharmaceuticals Inc Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $8.34M, a 26.7% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)